Register entry
Breckenridge Pharmeceutical, Inc.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | OMEPRAZOLE | capsule, delayed release pellets | 51991-995DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing omeprazole
- NATCO PHARMA LIMITED5 sites · 108 NDC
- DISHMAN CARBOGEN AMCIS LIMITED2 sites · 23 NDC
- SRINI PHARMACEUTICALS PRIVATE LIMITED2 sites · 16 NDC
- Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.2 sites · 6 NDC
- Smilax Laboratories Limited2 sites · 4 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Professional Compounding Centers of America dba PCCA1 site · 487 NDC
- Kalchem International Inc.1 site · 89 NDC
- XENEX LABORATORIES INC1 site · 38 NDC
- Towa Pharmaceutical Europe, S.L.1 site · 6 NDC
Enquiry
Common questions
- Is Breckenridge Pharmeceutical, Inc. FDA approved?
- Breckenridge Pharmeceutical, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Breckenridge Pharmeceutical, Inc. make?
- 1 product is listed under Breckenridge Pharmeceutical, Inc. in the openFDA NDC Directory, most often as capsule, delayed release pellets. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.